Loss of function variants are part of the spectrum of pathogenic variation for DCM (LMNA), HCM (MYBPC3), and ARVC (PKP2), which is consistent with the reported clinical diagnoses of the patients carrying these variants. Here, MYBPC3 is linked to arrhythmogenic right ventricular cardiomyopathy.